These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31724469)

  • 1. Usefulness of the "Non-Slip Element" Percutaneous Transluminal Angioplasty Balloon in the Treatment of Femoropopliteal Arterial Lesions.
    Karashima E; Yoda S; Yasuda S; Kajiyama S; Ito H; Kaneko T
    J Endovasc Ther; 2020 Feb; 27(1):102-108. PubMed ID: 31724469
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty of Chronic Femoropopliteal Occlusions.
    Tan M; Urasawa K; Koshida R; Haraguchi T; Kitani S; Igarashi Y; Sato K
    J Endovasc Ther; 2018 Apr; 25(2):192-200. PubMed ID: 29429382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
    Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Scoring Balloons on Percutaneous Transluminal Angioplasty Outcomes in Femoropopliteal Lesions.
    Horie K; Tanaka A; Taguri M; Inoue N
    J Endovasc Ther; 2020 Jun; 27(3):481-491. PubMed ID: 32249658
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease.
    Fujihara M; Takahara M; Sasaki S; Nanto K; Utsunomiya M; Iida O; Yokoi Y
    J Endovasc Ther; 2017 Jun; 24(3):367-375. PubMed ID: 28351208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Prolonged Inflation Times During Plain Balloon Angioplasty on Angiographic Dissection in Femoropopliteal Lesions.
    Horie K; Tanaka A; Taguri M; Kato S; Inoue N
    J Endovasc Ther; 2018 Dec; 25(6):683-691. PubMed ID: 30203701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissections After Infrainguinal Percutaneous Transluminal Angioplasty: A Systematic Review and Current State of Clinical Evidence.
    Armstrong EJ; Brodmann M; Deaton DH; Gray WA; Jaff MR; Lichtenberg M; Rundback JH; Schneider PA
    J Endovasc Ther; 2019 Aug; 26(4):479-489. PubMed ID: 31204592
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
    Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
    J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple classification and clinical outcomes of angiographic dissection after balloon angioplasty for femoropopliteal disease.
    Kobayashi N; Hirano K; Yamawaki M; Araki M; Sakai T; Sakamoto Y; Mori S; Tsutsumi M; Honda Y; Ito Y
    J Vasc Surg; 2018 Apr; 67(4):1151-1158. PubMed ID: 29242063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty.
    Bosiers M; Scheinert D; Hendriks JM; Wissgott C; Peeters P; Zeller T; Brodmann M; Staffa R;
    J Vasc Surg; 2016 Jul; 64(1):109-16. PubMed ID: 27139789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Factors of Severe Dissection after Balloon Angioplasty for Femoropopliteal Artery Disease.
    Hong H; Park UJ; Roh YN; Kim HT
    Ann Vasc Surg; 2021 Nov; 77():109-115. PubMed ID: 34428439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scoring Balloon Reduces the Severity of Dissection and Stent Implantation Rate in Superficial Femoral Artery Angioplasty Compared to Plain Balloon.
    Hong H; Park UJ; Roh YN; Kim HT
    Vasc Endovascular Surg; 2021 Feb; 55(2):135-142. PubMed ID: 33111648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions.
    Zeller T; Lopez L; Pigott JP
    J Endovasc Ther; 2019 Jun; 26(3):333-341. PubMed ID: 31106694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.
    Iida O; Urasawa K; Komura Y; Soga Y; Inoue N; Hara H; Yajima J; Nakamura S; Ohki T; Ando H; Hirano K; Horita Y; Kichikawa K; Yokoi Y; Miyamoto A; Nakamura M; Takahara M; Mano T; Nanto S
    J Endovasc Ther; 2019 Apr; 26(2):158-167. PubMed ID: 30702021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
    Kamioka N; Soga Y; Kuramitsu S; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Suematsu N; Shintani Y; Miyashita Y; Takahashi H; Tsuchiya T; Shinozaki N; Okazaki S; Ando K
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):790-797. PubMed ID: 28722294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
    Bausback Y; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    J Endovasc Ther; 2017 Aug; 24(4):459-467. PubMed ID: 28558502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.